Cargando…

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

The platinum compound oxaliplatin has been shown to be an effective chemotherapeutic agent for the treatment of colorectal cancer. In this study, we investigate the molecular mechanisms of action of oxaliplatin to identify means of predicting response to this agent. Exposure of colon cancer cells to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arango, D, Wilson, A J, Shi, Q, Corner, G A, Arañes, M J, Nicholas, C, Lesser, M, Mariadason, J M, Augenlicht, L H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409767/ https://www.ncbi.nlm.nih.gov/pubmed/15545975 http://dx.doi.org/10.1038/sj.bjc.6602215

Ejemplares similares

c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis
por: Arango, D, et al.
Publicado: (2003)

c-erbB-2 is not a major factor in the development of colorectal cancer
por: McKay, J A, et al.
Publicado: (2002)

Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth
por: Kaneko, K, et al.
Publicado: (2004)

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
por: Waas, E T, et al.
Publicado: (2002)

RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma
por: Shyu, R-Y, et al.
Publicado: (2003)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002)

Nuclear β-catenin expression is closely related to ulcerative growth of colorectal carcinoma
por: Chiang, J M, et al.
Publicado: (2002)

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma
por: Kummar, S, et al.
Publicado: (2002)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

Prognostic significance of dysadherin expression in advanced colorectal carcinoma
por: Aoki, S, et al.
Publicado: (2003)

Elevated c-Src is linked to altered cell–matrix adhesion rather than proliferation in KM12C human colorectal cancer cells
por: Jones, R J, et al.
Publicado: (2002)

Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma
por: Werther, K, et al.
Publicado: (2002)

Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
por: Hanke, B, et al.
Publicado: (2003)

Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling
por: Lee, Y-F, et al.
Publicado: (2003)

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
por: Mamot, C, et al.
Publicado: (2003)

Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers
por: Shono, Y, et al.
Publicado: (2003)

CpG island methylation is a common finding in colorectal cancer cell lines
por: Suter, C M, et al.
Publicado: (2003)

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line
por: Banerjee, R, et al.
Publicado: (2004)

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
por: Hoskin, P J, et al.
Publicado: (2003)

KOC is a novel molecular indicator of malignancy
por: Mueller, F, et al.
Publicado: (2003)

Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis
por: Gasbarri, A, et al.
Publicado: (2004)

Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients
por: Temam, S, et al.
Publicado: (2003)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer
por: Damera, A, et al.
Publicado: (2003)

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
por: Hardt, P D, et al.
Publicado: (2004)

Liver fatty acid binding protein expression in colorectal neoplasia
por: Lawrie, L C, et al.
Publicado: (2004)

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
por: Koukourakis, M I, et al.
Publicado: (2003)

Transcriptional impairment of β-catenin/E-cadherin complex is not associated with β-catenin mutations in colorectal carcinomas
por: Garinis, G A, et al.
Publicado: (2003)

Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas
por: Kikuchi, R, et al.
Publicado: (2002)

Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women
por: Masumoto, N, et al.
Publicado: (2003)

ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells
por: Mousli, M, et al.
Publicado: (2003)

No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas
por: Yamamoto, T, et al.
Publicado: (2003)

Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells
por: Hövelmann, S, et al.
Publicado: (2004)

CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours
por: Gonzalez-Gomez, P, et al.
Publicado: (2003)

Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients
por: Kubota, T, et al.
Publicado: (2002)

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
por: Kupryjańczyk, J, et al.
Publicado: (2003)

MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFβ2
por: Choudhury, A, et al.
Publicado: (2004)

CXCR4/CXCL12 expression and signalling in kidney cancer
por: Schrader, A J, et al.
Publicado: (2002)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_u5lovl2q7o0iv2f30u9l0n1bdc